Roles of replication fork-interacting and Chk1-activating domains from claspin in a DNA replication checkpoint response by Lee, Joon et al.
Molecular Biology of the Cell
Vol. 16, 5269–5282, November 2005
Roles of Replication Fork-interacting and Chk1-activating
Domains from Claspin in a DNA Replication Checkpoint
Response□D
Joon Lee,* Daniel A. Gold,* Anna Shevchenko,† Andrej Shevchenko,† and
William G. Dunphy*
*Division of Biology, California Institute of Technology, Pasadena, CA 91125; and †Max Planck Institute of
Molecular Cell Biology and Genetics, 01307 Dresden, Germany
Submitted July 25, 2005; Revised August 25, 2005; Accepted August 29, 2005
Monitoring Editor: Mark Solomon
Claspin is essential for the ATR-dependent activation of Chk1 in Xenopus egg extracts containing incompletely replicated
DNA. Claspin associates with replication forks upon origin unwinding. We show that Claspin contains a replication
fork-interacting domain (RFID, residues 265–605) that associates with Cdc45, DNA polymerase , replication protein A,
and two replication factor C complexes on chromatin. The RFID contains two basic patches (BP1 and BP2) at amino acids
265–331 and 470–600, respectively. Deletion of either BP1 or BP2 compromises optimal binding of Claspin to chromatin.
Absence of BP1 has no effect on the ability of Claspin to mediate activation of Chk1. By contrast, removal of BP2 causes
a large reduction in the Chk1-activating potency of Claspin. We also find that Claspin contains a small Chk1-activating
domain (residues 776–905) that does not bind stably to chromatin, but it is fully effective at high concentrations for
mediating activation of Chk1. These results indicate that stable retention of Claspin on chromatin is not necessary for
activation of Chk1. Instead, our findings suggest that only transient interaction of Claspin with replication forks
potentiates its Chk1-activating function. Another implication of this work is that stable binding of Claspin to chromatin
may play a role in other functions besides the activation of Chk1.
INTRODUCTION
Checkpoint control mechanisms ensure the integrity of the
genome by preventing the transmission of incompletely rep-
licated or damaged DNA to progeny cells (Osborn et al.,
2002; McGowan and Russell, 2004; Sancar et al., 2004;
O’Connell and Cimprich, 2005). For example, the DNA rep-
lication checkpoint monitors whether DNA synthesis occurs
normally throughout S phase. When problems become evi-
dent, this regulatory network forestalls premature entry into
mitosis and stabilizes aberrant replication forks until normal
replication can resume and subsequently reach completion.
The manifestation of this checkpoint is most obvious when
DNA replication forks stall at sites of exogenously inflicted
DNA damage. However, this pathway also operates when
spontaneous errors arise during replication or the replica-
tion apparatus encounters difficult-to-replicate sequences.
Checkpoint pathways contain a variety of regulatory pro-
teins that detect the status of the genome and that relay this
information to effector enzymes that regulate downstream
processes (Melo and Toczyski, 2002; Osborn et al., 2002;
Sancar et al., 2004). In the DNA replication checkpoint, ATR
functions at or near the top of this regulatory hierarchy
(Abraham, 2001). ATR is a member of the phosphoinositide
kinase-related family of protein kinases that also includes
ATM. One key function of ATR involves activation of the
checkpoint effector kinase Chk1 (Guo et al., 2000; Hekmat-
Nejad et al., 2000; Liu et al., 2000). Significantly, ATR cannot
carry out this function alone but must cooperate with nu-
merous other proteins. For example, ATR possesses a con-
served binding partner called ATRIP (Cortez et al., 2001).
Other collaborating factors include the checkpoint clamp
assembly of Rad9, Rad1, and Hus1 (the 9-1-1 complex) (San-
car et al., 2004). A checkpoint clamp loader consisting of
Rad17 and the four small subunits of replication factor C
(RFC) is responsible for deposition of the 9-1-1 complex onto
DNA. The checkpoint clamp loader and clamp proteins
most likely interact with boundaries between single-
stranded and double-stranded regions of DNA that would
be present in incompletely replicated or damaged DNA
(You et al., 2002; Ellison and Stillman, 2003; Lee et al., 2003;
Zou et al., 2003).
ATR as well as ATM also work together with a class of
proteins known as mediators (McGowan and Russell, 2004;
O’Connell and Cimprich, 2005). In vertebrates, these pro-
teins consist of Claspin and various BRCA1 C-terminal re-
peat (BRCT)-containing proteins, including TopBP1, 53BP1,
Mdc1, and BRCA1 itself (Kumagai and Dunphy, 2000; Can-
man, 2003; Chini and Chen, 2003). These mediators either
have been shown to or are thought to serve as adaptors
between ATR/ATM and the downstream kinases Chk1 and
Chk2. In addition, accumulating evidence has indicated that
mediator proteins may function as sensors of chromatin
structures. For example, in response to double-stranded
DNA breaks, mammalian 53BP1 and its fission yeast relative
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Crb2 recognize methylated forms of lysine 79 in histone H3
and lysine 20 in histone H4, respectively (Huyen et al., 2004;
Sanders et al., 2004). These histone methylations do not vary
in response to DNA damage. Instead, modified histones
may become inappropriately exposed at sites of damage.
Furthermore, 53BP1, Crb2, and other BRCT-containing pro-
teins respond to the phosphorylation of histone H2AX and
H2A in mammals and fission yeast, respectively (Celeste et
al., 2003; Nakamura et al., 2004). This type of histone phos-
phorylation is not required for initial recruitment of media-
tor proteins to sites of damage, but it is necessary for their
stable incorporation into damage-induced foci. These obser-
vations suggest that the interaction of mediator proteins
with chromatin is multifaceted and may fulfill multiple
functions.
We have been studying the DNA replication checkpoint in
Xenopus egg extracts. In this system, the DNA replication
inhibitor aphidicolin elicits the formation of stalled replica-
tion forks, which in turn trigger the activation of Xenopus
Chk1 (Xchk1) (Kumagai et al., 1998; Michael et al., 2000). The
Xenopus homologue of ATR (Xatr) is responsible for the
phosphorylation-dependent activation of Xchk1 (Guo et al.,
2000; Hekmat-Nejad et al., 2000). This process also requires
the mediator protein Claspin in Xenopus egg extracts and
human cells (Kumagai and Dunphy, 2000; Chini and Chen,
2003; Lin et al., 2004). Claspin associates directly with Xchk1
and thereupon strongly enhances the ability of Xatr to phos-
phorylate Xchk1 (Kumagai and Dunphy, 2003; Kumagai et
al., 2004). In addition, Claspin displays dynamic spatial lo-
calization by associating with replication forks during S
phase (Lee et al., 2003). This binding requires Xcdc45 and
Cdk2 but not replication protein A (RPA), suggesting that
Claspin associates with incipient replication forks at around
the time of DNA unwinding (Lee et al., 2003). The initial
binding of Claspin occurs before Xatr-Xatrip and the repli-
cation factor C (RFC) proteins and therefore must involve, at
least in part, chromatin structures that are distinct from
those recognized by these proteins. The budding yeast ho-
mologue of Claspin called Mrc1 likewise associates specifi-
cally with replication forks (Katou et al., 2003; Osborn and
Elledge, 2003). These observations imply that Claspin and its
homologues may also function as checkpoint sensor pro-
teins.
In this study, we have explored the mechanism by which
Claspin associates with the DNA replication apparatus to
understand the purpose of this interaction. Our results in-
dicate that Claspin uses a conserved domain to interact with
key replication and checkpoint proteins, including Cdc45,
DNA polymerase  (Pol ), RPA, and both the replicative
and Rad17-containing RFC complexes. Interestingly, al-
though a portion of this domain is required for optimal
activation of Chk1, stable retention of Claspin on chromatin
is not essential for its Chk1-activating function.
MATERIALS AND METHODS
Xenopus Egg Extracts
Extracts from Xenopus eggs were prepared as described previously (Lee et al.,
2003). The DNA replication checkpoint was induced by the addition of
demembranated Xenopus sperm nuclei (3000/l) and aphidicolin (100 g/
ml). Caffeine (5 mM) was used to override this checkpoint response. Isolation
of nuclear and chromatin fractions from egg extracts was described previ-
ously (Lee et al., 2003).
Antibodies
Antibodies against Xenopus Claspin, RPA70, Xorc2, phospho-Ser864 of
Claspin, Xatr, Xatrip, Xchk1, Xrad17, and Xhus1 were described previously
(Kumagai and Dunphy, 2003; Lee et al., 2003; Kumagai et al., 2004). Antibodies
against Xenopus RFC40 and proliferating cell nuclear antigen (PCNA) were
raised against bacterially expressed His6-tagged proteins containing either
residues 1–320 of RFC40 or full-length PCNA, respectively. The sequence of
Xenopus RFC40 (expressed sequence tag database XGI TC34364) showed
89.6% identity at the amino acid level with human RFC40. Anti-Xcdc45 and
anti-p60 of Pol  antibodies were raised as described previously (Mimura and
Takisawa, 1998; Waga et al., 2001). These antibodies were all affinity-purified
with their antigens. Antisera against Xenopus importin , Xenopus Pol  (p125
subunit), Xsld5, Xenopus cyclin E, and Xmcm7 were generously supplied by
D. Go¨rlich (Universita¨t Heidelberg, Heidelberg, Germany), S. Waga (Osaka
University, Osaka, Japan), H. Takisawa (Osaka University, Osaka, Japan), P.
Jackson (Stanford University, Stanford, CA), and J. Blow (University of
Dundee, Dundee, Scotland, United Kingdom), respectively. Antisera against
human RFC37 and Xenopus RFC140 were the kind gifts of J. Hurwitz (Memorial
Sloan-Kettering Cancer Center, New York, NY) and S. Waga, respectively. Anti-
human Chk1 phospho-Ser345 antibody was purchased from Cell Signaling Tech-
nology (Beverly, MA). Purified control rabbit IgG and anti-FLAG monoclonal
antibodies were obtained from Zymed Laboratories (South San Francisco, CA)
and Sigma-Aldrich (St. Louis, MO), respectively. Immunodepletion procedures
for Claspin, Xcdc45, and RPA were described previously (Lee et al., 2003).
Recombinant Proteins
The pBluescript vector was engineered to encode a nuclear localization signal
(NLS) (TPPKKKRKVEDP) (Moore et al., 2002) fused upstream of Claspin
fragments for in vitro protein synthesis. The same NLS was inserted into
pGEX-4T-3 (GE Healthcare, Little Chalfont, Buckinghamshire, United King-
dom) to make glutathione S-transferase (GST)-NLS fusion constructs of
Claspin. Baculoviruses encoding full-length or truncated His6-Claspin-FLAG
proteins were generated with the Bac-to-Bac system with a His6 tag and
FLAG epitope (DYKDDDDK) at the N-terminal and C-terminal ends, respec-
tively. Various Claspin mutants (internal deletions or amino acid substitu-
tions) were produced through PCR-based mutagenesis by standard methods.
Recombinant Claspin proteins were expressed and purified from baculovirus-
infected insect cells or bacteria as described previously (Kumagai and Dun-
phy, 2003). 35S-labeled proteins were synthesized in vitro with the TnT system
(Promega, Madison, WI). Human GST-p27 (gift from T. Hunter, Salk Institute,
La Jolla, CA) was expressed in bacteria and purified with glutathione agarose.
Identification of Claspin-binding Proteins from Egg
Extracts
Claspin was immunoprecipitated from 5 ml of interphase egg extract with 200
g of anti-Claspin antibodies cross-linked to Affiprep protein-A beads (Bio-
Rad, Hercules, CA). The beads were washed four times with immunoprecipi-
tation (IP) buffer B (10 mM HEPES-KOH, pH 7.6, 0.5 M NaCl, 0.1% NP-40, and
20 mM -glycerolphosphate). Samples were boiled in SDS buffer, concen-
trated, separated by SDS-PAGE, transferred to nitrocellulose, and stained
with Ponceau S. Protein bands containing p55 and p90 were excised and
subjected to chemical sequencing and nanoelectrospray tandem mass spec-
trometry in the Howard Hughes Medical Institute protein sequencing facility
at University of California (Berkeley, CA). Sequences from p55 (KXTQH/AP
and KYFXGEEA) and p90 (KFYAK and KTLATWATK) corresponded to
importin  and , respectively.
Identification of Claspin-binding Proteins in Chromatin
Eluates
For analytical experiments, sperm nuclei reconstituted in interphase egg
extract (1 ml) were collected through a sucrose cushion (Lee et al., 2003).
Nuclei were resuspended in 100 l of HEPES-buffered saline (10 mM HEPES-
KOH, pH 7.6, and 150 mM NaCl) supplemented with 10% dimethyl sulfoxide
and 5 mM caffeine, incubated at room temperature for 30 min, and cooled on
ice for 20 min. An equal volume of elution buffer (10 mM HEPES-KOH, pH
7.6, 1 M NaCl, and 1% NP-40) was added, and the incubation was continued
on ice for 20 min. After dilution with 200 l of 10 mM HEPES-KOH, pH 7.6,
soluble proteins were recovered by centrifugation at 14,000 rpm in an Eppen-
dorf centrifuge for 10 min. Antibodies (2.5 g) cross-linked to protein A beads
were incubated with these preparations for 1 h at 4°C, washed twice with IP
buffer C (10 mM HEPES-KOH, pH 7.6, 150 mM NaCl, 0.1% CHAPS, 2.5 mM
EGTA, and 20 mM -glycerolphosphate), and subjected to SDS-PAGE.
For identification by protein sequencing, four batches of egg extract totaling
50 ml were used to reconstitute nuclei (3000/l) in the presence of aphidicolin
and caffeine. Proteins were removed from chromatin by elution with 0.5 M
NaCl and immunoprecipitated with anti-Claspin antibodies as described
above. Bound proteins were concentrated, separated by SDS-PAGE, stained
with Coomassie Blue, and subjected to in-gel trypsin digestion as described
previously (Shevchenko et al., 1996). Methods for nanoelectrospray tandem
mass spectrometry of tryptic peptides and analysis of the sequencing data
were carried out exactly as described previously (Shevchenko et al., 2001,
2003; Yoo et al., 2004). The following protein identifications were obtained:
p180 (Claspin, 10 peptides), p150 (RFC140, 3 peptides), and p65 (RPA70, 3
peptides). p36-40 contained RFC36 (2 peptides), RFC37 (5 peptides), RFC38 (2
peptides), and RFC40 (5 peptides).
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Oligonucleotide Binding Assay
Preparation of magnetic beads coated with DNA oligonucleotides and assay
conditions for binding of proteins in egg extracts to these beads were de-
scribed previously (Lee et al., 2003). For the double-stranded template, an-
nealed (dA)70-(dT)70 was prepared as described previously (Kumagai and
Dunphy, 2000). For the 30d-40s branched DNA, the following oligonucleo-
tides were annealed: 5-ACTGATTACGGTGCTGCTTATCGATGGTTTGC-
AGTGCTCGCATGGAGCTGGTTTCCGGCCTTGCTAATGG and 5-biotin-
CCATTAGCAAGGCCGGAAACCAGCTCCATGATCATTGGCAATCATTG-
GCACAACGATCAGCCAACTAAAC. Oligonucleotides were added to egg
extracts at a final concentration of 5.5 nM.
RESULTS
Search for Claspin-interacting Proteins in Cytoplasmic
Egg Extracts
To probe the mechanism by which Claspin promotes the
phosphorylation of Xchk1 in Xenopus egg extracts that con-
tain incompletely replicated DNA, we attempted to find
Claspin-interacting proteins. In particular, we wished to
evaluate whether Claspin could recognize specific compo-
nents of the DNA replication apparatus. We first searched
for Claspin-interacting proteins by immunoprecipitating
Claspin from whole cytoplasmic egg extracts (Figure 1A).
We identified two prominent binding proteins at 55 and 90
kDa as Xenopus importins  and , respectively (see Materi-
als and Methods). The binding of importin  was verified by
immunoblotting with anti-importin  antibodies (Figure
1A). These proteins could not be found in anti-Claspin im-
munoprecipitates from nuclear extracts (see below), which is
consistent with the fact that importins dissociate from their
cargo upon nuclear entry. In further studies, we found that
importin  binds well to a GST peptide containing the
C-terminal 56 amino acids of Claspin (residues 1230–1285),
which contains sequences that closely resemble a NLS (our
unpublished data).
Claspin Interacts with Key Replication Proteins on
Chromatin
Because we could not identify any additional Claspin-bind-
ing proteins in cytoplasmic extracts, we examined whether
Claspin associates specifically with other proteins upon
binding to chromatin. To pursue these experiments, we first
considered the richest potential source of Claspin-interact-
ing, chromatin-binding proteins. Previously, we observed
that Claspin accumulates on chromatin in aphidicolin-
treated extracts. The binding of Claspin increases dramati-
cally upon the further addition of caffeine. Recent studies
have indicated that caffeine stimulates the firing of inhibited
replication origins in aphidicolin-treated chromatin (Yanow
et al., 2003; Marheineke and Hyrien, 2004; Shechter et al.,
2004). Therefore, the increased binding of Claspin to chro-
matin in such extracts seems to reflect binding to numerous
additional origins of replication. Under this condition,80%
of the nuclear Claspin is bound to chromatin. Hence, for the
experiments described below, we have searched for Claspin-
binding proteins on chromatin in extracts containing both
aphidicolin and caffeine.
Next, we assessed different methods for immunoprecipi-
tation of the chromatin-derived form of Claspin. Some com-
monly used techniques, such as nuclease digestion or soni-
cation of the chromatin before immunoprecipitation,
resulted in anti-Claspin immunoprecipitates that were con-
taminated by general DNA binding proteins. We concluded
that these methods yielded chromatin fragments that were
large enough to bridge Claspin nonspecifically with other
proteins during immunoprecipitation. As an alternative, we
attempted to extract Claspin from chromatin by mild salt
treatment under conditions that would maintain certain pro-
tein–protein interactions that had initially formed on the
DNA. For this purpose, we exposed chromatin to increasing
concentrations of NaCl (i.e., 0.25, 0.5, 0.75, and 1 M). As
shown in Figure 1B, treatment with 0.25 M NaCl led to a
substantial decrease in chromatin-bound Claspin, and 0.5 M
NaCl removed Claspin almost completely. Various replica-
tion and checkpoint regulatory proteins, including Xorc2,
Xmcm7, Xcdc45, RPA70, RFC40, PCNA, Xatr, and Xhus1,
each displayed their own characteristic salt elution profile.
We immunoprecipitated Claspin from the salt eluates and
immunoblotted for various key replication and checkpoint
proteins. We could readily detect Xcdc45, RPA70, and
RFC40 in the anti-Claspin immunoprecipitates from the 0.5
M NaCl eluate, and, to a lesser extent, in the 0.75 M eluate
(Figure 1B). The interaction between Claspin and RFC40 was
very strong, remaining even in the presence of 1 M NaCl. It
has been established that Xcdc45, Claspin, and Pol  load
onto replication origins around the same time (Mimura et al.,
2000; Lee et al., 2003). Therefore, we also immunoblotted the
anti-Claspin immunoprecipitates with anti-Pol  antibodies,
but we could detect only a very faint signal for Pol  in the
0.5 and 0.75 M NaCl eluates (our unpublished data). How-
ever, we were able to demonstrate an interaction between
Claspin and Pol  by a different method (see below). We
could not detect the specific presence of Pol  or Pol  in
anti-Claspin immunoprecipitates by immunoblotting with
anti-Pol  or anti-Pol  antibodies (our unpublished data).
Finally, we could not find Xatr, Xhus1, Xorc2, Xmcm7, or
PCNA in anti-Claspin immunoprecipitates from any of the
salt eluates. These observations argue that our procedure
detects specific protein–protein interactions that become es-
tablished on chromatin. Furthermore, the absence of abun-
dant DNA binding proteins such as Xorc2 indicates that
these immunoprecipitates do not contain DNA fragments
with contaminating proteins.
To identify Claspin-binding proteins in a more general
manner, we analyzed anti-Claspin immunoprecipitates by
silver staining (Figure 1C). We observed specifically associ-
ated bands at 150, 140, and 65 kDa as well as a cluster of
bands at 36–40 kDa. Analysis by nanoelectrospray tandem
mass spectrometry indicated that p150 and p65 correspond
to the largest subunits of RFC (RFC140) and RPA (RPA70),
respectively. In addition, p36-40 contained all four small
subunits of RFC (e.g., RFC36, RFC37, RFC38, and RFC40).
p140 is still under investigation. We verified these associa-
tions by immunoblotting anti-Claspin immunoprecipitates
with specific antibodies that recognize the Xenopus versions
of RFC140 and RPA70 (Figure 1D). We could also detect the
presence of RFC37 and RFC40 by immunoblotting with
antibodies against these proteins. Because the small RFC
subunits are also present in other clamp loader complexes,
such as the one containing Rad17, we asked whether Claspin
could also associate with Rad17. As shown in Figure 1D,
Xrad17 could also be found in anti-Claspin immunoprecipi-
tates from chromatin by immunoblotting with anti-Xrad17
antibodies.
Claspin Interacts Successively with Xcdc45 and RFC
Complexes
To corroborate these results, we carried out various recip-
rocal immunoprecipitation experiments. First, we asked
whether complexes containing Xcdc45 and Claspin could
also be identified by immunoprecipitation with anti-Xcdc45
antibodies. As shown in Figure 2A, we could clearly detect
Claspin as well as RPA70, RFC40, and Xrad17 in anti-Xcdc45
immunoprecipitates from 0.5 M NaCl eluates of chromatin.
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In addition, we could find Xmcm7 and Xsld5, components of
the MCM and GINS complexes, respectively, in anti-Xcdc45
immunoprecipitates of both 0.5 and 1 M NaCl chromatin
eluates. Consistent with the results described above, we
found Xcdc45, RPA70, RFC40, and Xrad17 in anti-Claspin
immunoprecipitates that were prepared in parallel. How-
ever, we could not find either Xmcm7 or Xsld5 in anti-
Claspin immunoprecipitates. Therefore, Claspin does not
associate with Xcdc45 indirectly through either the MCM or
GINS complexes.
Next, we carried out immunoprecipitations with anti-
RPA70, anti-RFC40, and anti-Xrad17 antibodies. We could
find Claspin in anti-RFC40 and anti-Xrad17, but not in anti-
RPA70 immunoprecipitates (Figure 2B). We also performed
immunoprecipitations of the chromatin eluates with anti-
bodies against Xhus1, a component of the 9-1-1 complex.
Consistent with the results obtained in the anti-Claspin im-
munoprecipitation studies, we could not detect any Claspin
in anti-Xhus1 immunoprecipitates from chromatin eluates
(Figure 2B). On the other hand, we could observe RPA70,
Figure 1. Identification of Claspin-interact-
ing proteins in cytoplasmic and chromatin
fractions from Xenopus egg extracts. (A)
Claspin-binding proteins from egg extracts.
IP was performed with control (lane 1) or
anti-Claspin antibodies (lane 2) from inter-
phase egg extracts. Samples were analyzed
by silver staining (top) and immunoblotted
for Xenopus importin  (bottom). H, IgG
heavy chain. (B) Interaction of Claspin with
proteins on chromatin. Chromatin-binding
proteins were eluted from reconstituted nu-
clei (derived from 250 l of egg extract) with
various concentrations of NaCl and immuno-
precipitated with anti-Claspin antibodies
(lanes 4–8). Chromatin fractions after salt
elution were loaded in lanes 9–13. In parallel,
whole egg extracts (50 l) were immunopre-
cipitated with control (lane 2) and anti-
Claspin antibodies (lane 3). Lane 1 depicts 1
l of egg extract. Samples were immuno-
blotted for the indicated proteins. (C) Silver
staining of Claspin-binding proteins on chro-
matin. Interphase egg extracts were immuno-
precipitated with control (lane 1) and anti-
Claspin antibodies (lane 2). For lane 3,
chromatin proteins from nuclei reconstituted
in 1 ml of egg extract were eluted with 0.5 M
NaCl and immunoprecipitated with anti-
Claspin antibodies. Samples were subjected
to SDS-PAGE and silver staining. Bands des-
ignated as Claspin (p180), p150, p140, p65,
and p36–40 were prepared on a large scale
for identification by mass spectrometry (see
Materials and Methods). Asterisks in lane 2
denote importin  and . H and L, IgG heavy
and light chains. (D) Confirmation of
Claspin-binding proteins by immunoblot-
ting. Samples from C were immunoblotted
for the indicated proteins (lanes 2–4). Lane 1
depicts 1 l of egg extract.
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RFC40, and Xrad17 in these immunoprecipitates. It should be
noted that these results do not rule out an interaction of
Claspin with the 9-1-1 complex, because it is possible that the
chromatin elution procedure could disrupt such an association.
Previously, we reported that binding of Claspin to chro-
matin requires Xcdc45 but not RPA (Lee et al., 2003). More-
over, it is well established that the replicative and Rad17-
containing RFC complexes associate with replication forks
after RPA-stabilized unwinding of the DNA (You et al., 2002;
Ellison and Stillman, 2003; Lee et al., 2003; Zou et al., 2003).
Therefore, we examined whether the association of Claspin
with RFC proteins also requires RPA. We immunodepleted
RPA from egg extracts, prepared salt eluates of chromatin
fractions from these extracts, and then immunoprecipitated
Claspin from these eluates. As depicted in Figure 2C, we
could detect Xcdc45 but not RFC40 or Xrad17 in anti-Claspin
immunoprecipitates from RPA-depleted chromatin.
To characterize these interactions further, we analyzed the
binding partners of Xcdc45 in the absence of Claspin. As
shown in Figure 2D, Xcdc45 could bind well to RFC40 and
Xrad17 even in Claspin-depleted extracts. From these results,
we conclude that Claspin interacts first with Xcdc45 at replica-
tion forks and later associates with RFC complexes after RPA-
stabilized unwinding of the DNA. At this juncture, Xcdc45 also
forms connections with RFC proteins, but these interactions do
not require the presence of Claspin. These results, along with
the fact that the interactions of Claspin with Xcdc45 versus
RFC40 display different salt sensitivities, imply that Xcdc45
and RFC complexes associate with Claspin independently.
A Conserved N-Terminal Domain Mediates Interaction of
Claspin with Chromatin
To assess the functional significance of the interactions with
other proteins on chromatin, we attempted to map the chro-
Figure 2. Binding relationships between
Claspin and other proteins on chromatin. (A)
Immunoprecipitation with anti-Xcdc45 anti-
bodies. Control (lanes 2–4), anti-Xcdc45
(lanes 5–7), and anti-Claspin antibodies
(lanes 8–10) were used for immunoprecipita-
tion from egg extracts (lanes 2, 5, and 8) or
chromatin eluates prepared with either 0.5 M
(lanes 3, 6, and 9) or 1 M NaCl (lanes 4, 7, and
10). The samples were immunoblotted for the
indicated proteins. Lane 1 depicts whole egg
extract. (B) Association of Claspin with
RFC40 and Xrad17. Egg extracts (lanes 2, 4, 6,
8, and 10) or 0.5 M NaCl chromatin eluates
(lanes 3, 5, 7, 9, and 11) were immunoprecipi-
tated with control (lanes 2 and 3), anti-Xeno-
pus RPA70 (lanes 4 and 5), anti-Xenopus
RFC40 (lanes 6 and 7), anti-Xrad17 (lanes 8
and 9), and anti-Xhus1 antibodies (lanes 10
and 11). Samples were immunoblotted for
various proteins as indicated. (C) RPA-de-
pendent association of RFC complexes with
Claspin. Claspin was immunoprecipitated
from egg extracts (lane 1) and from chroma-
tin eluates obtained from either mock-de-
pleted (lane 2) or RPA-depleted extracts (lane
3). Samples were immunoblotted for the in-
dicated proteins. (D) Xcdc45 interacts with
RFC independently of Claspin. Xcdc45 was
immunoprecipitated from either egg extracts
(lane 1) or chromatin eluates prepared from
either mock-depleted (lane 2) or Claspin-de-
pleted extracts (lane 3). Samples were immu-
noblotted for the indicated proteins.
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matin-binding region of Claspin. Because in vitro translated
35S-Claspin bound to chromatin as efficiently as endogenous
Claspin, we used 35S-labeled fragments of Claspin for the
initial phase of these experiments. We incubated various
truncated forms of Claspin in extracts containing aphidicolin
and caffeine and compared their ability to associate with
chromatin. For any fragment that did not contain the last 56
amino acids of Claspin, which are essential for nuclear up-
take, we incorporated an ectopic NLS into the polypeptide
chain. Because expression of individual fragments was vari-
able, we normalized the data by examining what percentage
of each fragment in nuclear fractions from the extracts could
associate with chromatin.
These studies indicated that a fragment containing resi-
dues 1–605 of Claspin binds exceptionally well to chromatin
(Figure 3A). By contrast, various fragments from the C-
terminal end of Claspin (e.g., 606-1285) showed little, if any,
stable interaction with chromatin. The binding of the 1–605
fragment to chromatin was sensitive to the Cdk inhibitor
p27, which inhibits firing of replication origins and thus
prevents binding of full-length Claspin to replication forks.
Furthermore, the interaction of this fragment with chroma-
tin depended on Xcdc45 but not on RPA (Figure 3B), as for
full-length Claspin.
Next, we asked whether the 1–605 fragment could asso-
ciate with the same replication and checkpoint proteins as
full-length Claspin. As shown in Figure 3C, we could im-
munoprecipitate the 1–605 fragment from chromatin frac-
tions with antibodies against Xcdc45, RPA70, RFC40, and
Xrad17. For these experiments, we also examined binding to
three major eukaryotic DNA polymerases, namely, Pol ,
Pol , and Pol . We could observe strong interaction of the
1–605 fragment with Pol , but no binding to either Pol  or
Pol . Finally, we could detect little or no binding of this
fragment to Xorc2, Xcut5, Xmcm7, PCNA, and Xhus1 in
immunoprecipitations with antibodies against these respec-
tive proteins. From these observations, we conclude that the
ability of Claspin to interact stably with chromatin resides in
the 1–605 fragment.
In further mapping studies, we found that removal of the
N-terminal 264 residues from the 1–605 fragment had no
effect on chromatin-binding efficiency (Figure 3A). However,
additional deletion of residues 265–331 abrogated binding.
Similarly, removal of residues 566–605 from the opposite
C-terminal end of this fragment also abolished interaction
with chromatin. From these studies, we conclude that a
region of Claspin stretching from residues 265–605 is in-
volved in the interaction with chromatin. To corroborate
these findings, we prepared a GST fusion protein containing
residues 265–605 of Claspin as well as an ectopic NLS. The
resulting GST-NLS-Claspin(265-605) protein could bind well
to chromatin (Figure 3D). The binding was much higher in
Claspin-depleted extracts. However, binding also occurred
in mock-depleted extracts, where inclusion of the fragment
also reduced the binding of endogenous Claspin to chroma-
tin. Therefore, the isolated 265–605 fragment of Claspin
fragment seems to compete with endogenous Claspin for a
finite number of binding sites in chromatin.
We named the 265–605 region of Claspin the replication
fork-interacting domain (RFID). Two recent studies have
shown that human Claspin and its fission yeast homologue
Mrc1 possess an in vitro DNA binding activity that is me-
diated by a DNA binding domain (DBD) (Sar et al., 2004;
Zhao and Russell, 2004). The DBD in human Claspin (resi-
dues 149–340) corresponds closely to residues 150–331 of
Xenopus Claspin, which overlap partially with the RFID.
During our studies, we noticed an interesting structural
feature of Claspin. Overall, Claspin is a very acidic protein
(pI  4.5), but it does contain four patches of basic amino
acids (residues 265–331, 470–600, 721–783, and 1157–1285)
with a pI value 10 (Figure 3A and Supplemental Figure
S1). These segments, which we denoted BP1, BP2, BP3, and
BP4, are highly conserved in metazoan Claspin, and the
yeast Mrc1 proteins also possess similar basic segments.
Notably, BP1 and BP2 define the boundaries of the RFID.
To evaluate directly whether the RFID can account for the
chromatin-binding ability of full-length Claspin, we pre-
pared various forms of full-length 35S-labeled Claspin with
mutations in this domain. We first examined relatively large
deletions in the protein. Initially, we deleted BP1 (BP1,
residues 265–331) and 40 amino acids encompassing the
C-terminal end of BP2 (BP2, residues 566–605). Moreover,
we also produced a mutant (6A) in which six residues within
BP1 that are highly conserved in metazoan Claspin proteins
and conserved to some extent in the yeast Mrc1 proteins
were changed to alanine. As shown in Figure 3E, when we
added 35S-labeled forms of the BP1, BP2, and 6A mu-
tants to undepleted egg extracts that contain their full com-
plement of endogenous Claspin, binding to chromatin was
abrogated or greatly reduced. By contrast, deletion of a
poorly conserved segment (residues 376–425) from the cen-
ter of the RFID, which we named the linker region (LK), had
negligible effect on binding to chromatin (Figure 3E). Con-
sistent with this observation, a bacterially expressed form of
GST-NLS-Claspin(265-605)LK bound well to chromatin
(our unpublished data) and associated specifically with
Xcdc45, Pol , RPA, and RFC40 in chromatin immunopre-
cipitation experiments (Figure 3F).
The BP1 Region of Claspin Is Not Required for Activation
of Chk1
Next, we sought to replace endogenous Claspin in egg ex-
tracts with various RFID mutants to assess their abilities to
function in checkpoint regulation. Toward this end, we cre-
ated mutations in a baculovirus-expressed version of
Claspin that contains His6 and FLAG tags at the N- and
C-terminal ends, respectively (His6-Claspin-FLAG). First,
we focused on the BP1 region. We produced BP1 and 6A
mutants of the baculovirus-expressed protein. We also pre-
pared a larger deletion (residues 150–331) that removes all
of BP1 and a block of upstream conserved sequences. The
deleted region in this latter mutant corresponds to the whole
DBD that was identified in human Claspin (Sar et al., 2004).
When we examined binding to chromatin in undepleted egg
extracts, we observed that none of the BP1, 6A, and (150-
331) mutants of baculovirus-expressed His6-Claspin-FLAG
could bind to chromatin (Figure 4A).
We proceeded to immunodeplete endogenous Claspin
from the extracts and to replace it with equivalent amounts
of these three mutants. First, we monitored the binding of
these mutants to chromatin in extracts that now lacked
endogenous Claspin. Unexpectedly, we observed that these
three mutants could now bind very well to chromatin (Fig-
ure 4B). This observation indicates that, in the absence of
competition from endogenous Claspin, these three mutants
retain significant ability to interact with chromatin. Further-
more, binding of the BP1 mutant to chromatin displayed
the same sensitivity to p27 as wild type Claspin (Figure 4C),
which argues this mutant binds specifically to replication
forks. We next examined the ability of these mutants to
mediate the activation of Xchk1 in response to treatment
with aphidicolin. As shown in Figure 4B, all three mutants
did not show any obvious difference from wild-type Claspin
in the ability to promote the phosphorylation of Xchk1.
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Together, these results indicate that neither BP1 nor the
whole DBD region is required for activation of Xchk1. De-
letion of BP1 or the DBD region does weaken the interaction
of Claspin with chromatin. However, without competition
from endogenous full-length Claspin, mutants lacking these
sequences bind very well to chromatin, which implies that
the remaining sequences of Claspin are sufficient for chro-
matin binding.
We have previously shown that Claspin does not bind
detectably to either single-stranded or double-stranded
DNA in egg extracts (Lee et al., 2003; Kumagai et al., 2004).
More recently, it was reported that recombinant human
Claspin seems to have a stronger in vitro binding activity
toward branched DNA than single-stranded or double-
stranded DNA (Sar et al., 2004). Therefore, we tested directly
whether endogenous Claspin in egg extracts can associate
Figure 3. Identification and characterization of an RFID from Claspin. (A) Chromatin-binding fragments of Claspin. Various 35S-labeled
fragments from the N-terminal half of Claspin were incubated for 100 min in egg extracts containing sperm chromatin, aphidicolin, and
caffeine. In this experiment, His6-Claspin(606-1285)-FLAG protein was used to represent the C-terminal half of the protein. Separate nuclear
(lane 1) and chromatin fractions were prepared (lanes 2 and 3). To assess dependency of chromatin binding on S-phase cyclin-dependent
kinase activity, extracts were treated with p27 (lane 3). Fragments were visualized by SDS-PAGE and phosphorimaging, except for the
606-1285 fragment, which was detected by immunoblotting with anti-FLAG antibodies. (B) The N-terminal domain of Claspin has very
similar chromatin binding properties as full-length Claspin. Extracts were subjected to an immunodepletion procedure with control (lanes
1 and 2), anti-Xcdc45 (lane 3), or anti-RPA antibodies (lane 4). Extracts were incubated with 35S-NLS-Claspin(1-605) and the indicated drugs.
Binding to chromatin was assessed by phosphorimaging or immunoblotting for endogenous proteins as indicated. (C) Interaction of
N-terminal domain of Claspin with various proteins on chromatin. 35S-NLS-Claspin(1-605) was incubated in egg extracts as in A. Aliquots
of chromatin eluates were immunoprecipitated with antibodies against the indicated proteins. The amount of bound 35S-fragment was
detected by SDS-PAGE and phosphorimaging. Lane 1 depicts 15% of the input chromatin eluate for each lane. (D) Interaction of bacterially
expressed RFID with chromatin. Mock-depleted (lanes 1–3) and Claspin-depleted extracts (lane 4) were incubated in the absence (lanes 1 and
2) or presence (lanes 3 and 4) of GST-NLS-Claspin(265-605). Chromatin fractions were prepared and immunoblotted with anti-Claspin (top)
and anti-GST antibodies (bottom). (E) Contribution of the RFID to the binding of full-length Claspin to chromatin in undepleted extracts.
35S-Labeled versions of full-length Claspin containing no deletion or deletions of residues 265–331 (BP1), 566–605 (BP2), or 376–425 (LK)
were prepared. For the 6A mutant, the highly conserved residues Gln287, Arg288, Leu289, Pro298, Tyr299, and His300 were all changed to
alanine. Nuclear accumulation (lane 1), chromatin binding (lane 2), and p27 sensitivity of chromatin binding (lane 3) were determined as
described in A. (F) Interaction of the RFID with replication proteins on chromatin. GST-NLS-Claspin(265-605)LK was incubated with egg
extracts as in A. Aliquots of chromatin eluates were immunoprecipitated with the indicated antibodies and immunoblotted with anti-GST
antibodies. Lane 1 depicts 15% of the input chromatin eluate for each sample.
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stably with branched DNA. As the template (30d-40s DNA),
we annealed two 70-mers that are complementary for 30
nucleotides at one end. As shown in Figure 4D, we could not
detect any binding of Claspin to either the branched 30d-40s
DNA or double-stranded (dA)70-(dT)70. On the other hand,
we could readily observe binding of RPA, Xatr, and Xatrip
to both templates. Furthermore, addition of caffeine or im-
munodepletion of RPA, both of which greatly increase the
binding of Claspin to chromatin in aphidicolin-containing
egg extracts (Lee et al., 2003), did not result in any binding of
Claspin to either template. The concentration of Claspin in
egg extracts (240 nM) (Kumagai and Dunphy, 2000) is well
over the observed Kd for in vitro binding of recombinant
human Claspin to branched DNA and thus should not be a
limiting factor. Together, these results suggest that endoge-
nous Claspin in egg extracts cannot bind stably to DNA
alone in egg extracts and that interaction with proteins at the
replication fork is necessary for stable association with chro-
matin.
The BP2 Region of Claspin Potentiates Its Chk1-
activating Function
To study the role of the RFID more systematically, we pre-
pared various mutant versions of Claspin containing serial
N-terminal deletions and compared their chromatin binding
properties in the absence of endogenous Claspin. We per-
formed these experiments in the presence of aphidicolin
and caffeine to maximize binding, but we obtained qual-
itatively similar binding in the presence of aphidicolin
alone (our unpublished data). As shown in Figure 5A,
both Claspin(265-1285) and Claspin(332-1285), which lack
part of or the entire DBD region, bind as well as full-length
Claspin to chromatin. On the other hand, further deletions
from the N-terminal end resulted in a dramatic drop in
association with chromatin. In particular, binding of the
Claspin(470-1285), Claspin(606-1285), and Claspin(774-1285)
fragments was markedly reduced, although the 470-1285
fragment did reproducibly bind somewhat better than the
606-1285 and 774-1285 fragments.
We proceeded to compare the ability of the various trun-
cation mutants to mediate the activation of Xchk1. For these
experiments, we immunodepleted endogenous Claspin
from egg extracts and then added back the various recom-
binant Claspin proteins at two different concentrations to
Claspin-FLAG (lanes 4–7) were incubated in the absence (lane 1) or
presence (lanes 2–7) of aphidicolin. Chromatin fractions were im-
munoblotted for Claspin and Xorc2 (top two panels). Phosphoryla-
tion of 35S-Xchk1 in nuclear fractions was assessed by phosphorim-
aging (third panel from top). For quantitation (bottom), the amount
of shifted 35S-Xchk1 was divided by the total 35S-Xchk1 in each lane
and normalized to the signal in the absence of aphidicolin (lane 1).
Results are the mean  SD for two experiments. (C) Binding of the
BP1 mutant to chromatin is sensitive to p27. Mock-depleted (lanes
1–3) and Claspin-depleted extracts (lanes 4–6) containing control
buffer (lanes 1–3) or the BP1 mutant of His6-Claspin-FLAG were
incubated with aphidicolin and caffeine. p27 was also added in
lanes 3 and 6. Nuclear (lanes 1 and 4) and chromatin fractions (lanes
2, 3, 5, and 6) were immunoblotted for the indicated proteins. (D)
Claspin does not bind detectably to branched DNA in egg extracts.
Magnetic beads coated with no DNA (lanes 2 and 6), (dA)70-(dT)70
(lanes 3–5), or 30d-40s DNA (a branched structure that contains a
30-mer double-stranded region and two 40-mer single-stranded
regions) (lanes 7–9) were incubated in mock-depleted (lanes 3, 4, 7,
and 8) or RPA-depleted egg extracts (lanes 5 and 9). Caffeine was
included in some incubations (lanes 4 and 8). The beads were
recovered, washed, and immunoblotted for the indicated proteins.
Lane 1 shows 1 l of egg extract.
Figure 4. Role of the BP1 region from the RFID in binding of
Claspin to chromatin and activation of Xchk1 in extracts lacking
endogenous Claspin. (A) Various His6-Claspin-FLAG proteins were
prepared from baculovirus-infected insect cells and added directly
into undepleted egg extracts containing sperm chromatin, aphidi-
colin, and caffeine. The proteins included full-length Claspin (WT)
(lanes 1 and 2), a deletion of residues 150–331 (lanes 3 and 4), and
a deletion of residues 265–331 (BP1, lanes 5 and 6), and the 6A
mutant (lanes 7 and 8). Nuclear (lanes 1, 3, 5, and 7) and chromatin
fractions (lanes 2, 4, 6, and 8) were immunoblotted with anti-FLAG
antibodies (top). Samples were also immunoblotted for Xorc2 as a
loading control (bottom). (B) Mock-depleted (lanes 1 and 2) and
Claspin-depleted extracts (lanes 3–7) containing control buffer
(lanes 1–3) or equivalent amounts of the indicated forms of His6-
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compare their relative potencies. In particular, we used mo-
lar concentrations corresponding to the amount of endoge-
nous Claspin (1) and a fivefold dilution of this amount
(0.2), respectively. Finally, we added sperm chromatin and
aphidicolin to the extracts and then monitored phosphory-
lation of Xchk1. We observed that the full-length, 332-1285,
and 470-1285 polypeptides all could restore phosphorylation
of Xchk1 in Claspin-depleted extracts at the both 1 and
0.2 concentrations (Figure 5B). However, the shorter frag-
ments of Claspin, namely, 606-1285 and 774-1285 were sig-
nificantly less potent at promoting the phosphorylation of
Xchk1. This effect was most evident at the diluted concen-
tration of these fragments. For example, an extract contain-
ing the 774-1285 mutant at the 0.2 concentration displayed
little or no phosphorylation of Xchk1. These observations
indicate that the C-terminal region of Claspin, which does
not bind strongly to chromatin, shows reduced capacity to
mediate the activation of Xchk1. However, the 470-1285
fragment seemed similar to full-length Claspin in the ability
to mediate phosphorylation of Xchk1, even though it did not
display the stable chromatin binding capacity of full-length
Claspin.
These observations suggested that all or part of the BP2
region in Claspin (residues 470 – 600) might be important
for checkpoint signaling. To pursue this possibility, we
prepared a mutant of full-length His6-Claspin-FLAG with
a deletion of residues 470 – 605 (BP2). Consistent with the
results observed for the smaller deletion of residues 566 –
605, the BP2 mutant could bind to chromatin in Claspin-
depleted extracts but not in undepleted extracts contain-
ing endogenous Claspin (Figure 5, C and D). When we
examined checkpoint regulation, we observed that
aphidicolin-treated extracts containing a fivefold dilution
of the BP2 mutant showed significantly reduced phos-
phorylation of Xchk1 (Figure 5E). Therefore, deletion of
BP2 seems to compromise the checkpoint-signaling po-
tency of Claspin.
Figure 5. C-Terminal fragments of Claspin
display reduced potency in mediating activa-
tion of Xchk1. (A) Full-length (residues
1–1285) and N-terminally truncated forms of
Claspin (residues 265-1285, 332-1285,
470-1285, 606-1285, and 774-1285) were pre-
pared as His6-Claspin-FLAG proteins in in-
sect cells and added into Claspin-depleted
extracts containing sperm chromatin, aphidi-
colin, and caffeine. Nuclear (lanes 1–6) and
chromatin fractions (lanes 7–12) were pre-
pared and immunoblotted with anti-FLAG
(top) and anti-Xorc2 antibodies (bottom). The
bars on right denote positions of the different
recombinant Claspin proteins. (B) Mock-de-
pleted (lanes 1 and 2) and Claspin-depleted
extracts (lanes 3–13) containing control buffer
(lanes 1–3) or the indicated forms of His6-
Claspin-FLAG (lanes 4–13) were incubated
in the absence (lane 1) or presence (lanes
2–13) of aphidicolin. Recombinant Claspin
proteins were added at a molar concentration
equal to (1) or one-fifth (0.2) that of en-
dogenous Claspin. Phosphorylation of 35S-
Xchk1 in nuclear fractions from the extracts
was assessed by phosphorimaging. (C) Wild-
type His6-Claspin-FLAG (lanes 1 and 2) and
a deletion mutant lacking residues 470–605
(BP2, lanes 3 and 4) were added into unde-
pleted egg extracts containing sperm chro-
matin, aphidicolin, and caffeine. Nuclear
(lanes 1 and 3) and chromatin fractions (lanes
2 and 4) were immunoblotted with anti-
FLAG (top) and anti-Xorc2 antibodies (bot-
tom). (D) Claspin-depleted extracts were pre-
pared and incubated in the presence of
aphidicolin with buffer alone (lane 1), wild-
type His6-Claspin-FLAG (lane 2), or the
BP2 mutant (lane 3). Chromatin fractions
were immunoblotted for Claspin (top) and
Xorc2 (bottom). (E) Phosphorylation of 35S-
Xchk1 was compared in extracts containing
the full-length, 470-1285, and BP2 versions
of Claspin at the indicated concentrations as
described in B.
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Figure 6. A small fragment from the C-terminal end of Claspin is sufficient at high concentrations for mediating phosphorylation of Xchk1.
(A) Mock-depleted (lanes 1 and 2) and Claspin-depleted extracts (lanes 3–12) were incubated with control buffer (lanes 1 and 2) and the
indicated dilutions of full-length His6-Claspin-FLAG (lanes 3–7) or the His6-Claspin(774-1285)-FLAG fragment (lanes 8–12) in the absence
(lane 1) or presence (lanes 2–12) of aphidicolin. Nuclear fractions were prepared and immunoblotted with anti-Claspin antibodies (top),
anti-FLAG antibodies to detect both full-length Claspin (second panel from top) and the 774-1285 fragment (third panel from the top), and
anti-PCNA antibodies (fourth panel from top). Note that the anti-Claspin antibodies do not detect the 774-1285 fragment. Phosphorylation
of 35S-Xchk1 was assessed by phosphorimaging (bottom). (B) Quantitation of results from A for full-length Claspin (closed circles) and the
774-1285 fragment (closed squares). (C) Phosphorylation of the 774-1285 fragment on Ser864. Mock-depleted (lanes 1 and 2) and Claspin-
depleted extracts (lanes 3–6) containing control buffer (lanes 1–3), full-length His6-Claspin-FLAG (lane 4), or His6-Claspin(774-1285)-FLAG
(lanes 5 and 6) at the indicated amounts relative to endogenous Claspin were incubated in the absence (lane 1) or presence (lanes 2–6) of
aphidicolin. Nuclear fractions were immunoblotted with anti-Claspin, anti-P-Ser864 of Claspin, and anti-FLAG antibodies as indicated. To
examine phosphorylation of Xchk1, samples were immunoblotted with anti-P-Ser344 of Xchk1 and anti-Xchk1 antibodies (bottom two
panels). (D) C-terminal fragments of Claspin fully rescue phosphorylation of Xchk1 at high concentrations. Mock-depleted (lanes 1 and 2) and
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The C-Terminal Region of Claspin Contains a Small
Chk1-activating Domain
These observations suggested that the C-terminal domain of
Claspin has a significantly reduced potency for activation of
Xchk1. To pursue this issue, we systematically compared the
potencies of full-length Claspin and the C-terminal 774-1285
fragment for mediating the activation of Xchk1 (Figure 6, A
and B). For this purpose, we immunodepleted endogenous
Claspin from egg extracts and added back different dilutions
of full-length Claspin and the 774-1285 fragment. This pro-
cedure enabled us to compare the relative potencies of the
two proteins. Significantly, full-length Claspin was highly
resistant to dilution, indicating that there is a large func-
tional surplus of Claspin in egg extracts. For example, we
observed half-maximal phosphorylation of Xchk1 in extracts
containing a concentration of recombinant full-length
Claspin 0.055 the level of endogenous Claspin (Figure
6B). By contrast, a molar concentration of the 774-1285 frag-
ment 1.8-fold greater than that of endogenous full-length
Claspin was required to elicit a similar extent of phosphor-
ylation. Therefore, the 774-1285 fragment seems to be 33-
fold less potent than full-length Claspin. To evaluate
whether the 774-1285 fragment acts by a similar mechanism
as full-length Claspin, we examined phosphorylation of
Claspin on Ser864, which is required for phosphorylation of
Xchk1 (Kumagai and Dunphy, 2003). As shown in Figure
6C, the 774-1285 fragment became very efficiently phosphor-
ylated on Ser864 in aphidicolin-treated extracts.
These results imply that the C-terminal region of Claspin
should contain the minimal sequences necessary to carry out
the biochemical process required for the ATR-dependent
phosphorylation of Xchk1. To identify these sequences, we
prepared various C-terminal fragments of Claspin as fusion
proteins containing GST and an ectopic NLS. The fusion
constructs were designed to contain the previously identi-
fied Chk1-binding domain of Claspin (CKBD, residues 847–
903), in which serines 864 and 895 must be phosphorylated
for binding to Xchk1 (Kumagai and Dunphy, 2003). We
could observe phosphorylation of Xchk1 in the presence of a
fragment from Claspin containing residues 776–956 but not
an overlapping fragment containing residues 844-1170 (Fig-
ure 6D). Further analysis indicated that a 130-amino acid
fragment containing amino acids 776–905 is sufficient for
restoring phosphorylation of Xchk1 to Claspin-depleted ex-
tracts (Figure 6, E and F). We named this fragment the
Chk1-activating domain (CKAD). The CKAD, as well as the
longer 776–956 and 774-1285 fragments, displayed little or
no binding to chromatin (Figure 6G). Importantly, however,
the CKAD is considerably less potent than full-length
Claspin. For example, in Figure 6E, we needed to add the
CKAD fragment at a sixfold molar excess over the amount of
endogenous Claspin, which is already in surplus, to observe
a similar extent of Xchk1 phosphorylation.
Overall, these findings indicate that the capacity of
Claspin to mediate the activation of Xchk1 resides in a small
C-terminal region containing no more than 130 amino acids.
However, sequences from the BP2 region greatly increase
the overall potency of Claspin for activation of Xchk1. De-
letion of BP2 weakens the interaction of Claspin with chro-
matin. On the other hand, a truncated form of Claspin
(residues 470-1285) that contains BP2 does not bind stably to
chromatin and nonetheless induces phosphorylation of
Xchk1 as efficiently as full-length Claspin. These observa-
tions indicate that stable retention of Claspin on chromatin is
not necessary for activation of Xchk1.
DISCUSSION
One characteristic of the checkpoint mediator protein
Claspin is that it interacts specifically with both normal and
stalled DNA replication forks during S phase. In this report,
we have investigated the mechanism and functional signif-
icance of this interaction. To this end, we have mapped the
regions of Claspin that enable binding to chromatin and
searched for chromatin-bound proteins that mediate this
interaction. Our studies have indicated that Claspin contains
a relatively large RFID that is responsible for interaction
with chromatin. This domain associates with Xcdc45, RPA,
and both the replicative and Rad17-containing RFC com-
plexes (Figure 7). We have also established that there is
specific binding of Claspin to one of the major replicative
DNA polymerases, namely, Pol . Therefore, Claspin inter-
acts with both essential replication proteins and a key check-
point regulator on chromatin. Consistent with these obser-
vations, it has been reported that budding yeast Mrc1 and
Cdc45 can be coimmunoprecipitated from nuclease digests
of chromatin (Katou et al., 2003). However, these studies did
not resolve whether Mrc1 and Cdc45 associate by protein–
protein interactions or simply bind near one another on the
same digested DNA fragments.
Claspin Interacts Successively with Replication Fork
Proteins
We have found that Xcdc45 forms a complex with Claspin
without loading of RPA or RFC onto chromatin. By contrast,
RFC depends upon the loading of RPA to interact with
Claspin. These dependencies reflect the hierarchy in which
these proteins associate with chromatin. Therefore, our re-
sults indicate that upon binding to chromatin Claspin inter-
acts first with Xcdc45. After unwinding of the DNA, loading
of RPA, and synthesis of initiating primers, the replicative
RFC complex would recognize the 3 recessed ends of nas-
cent DNA strands. At this point, RFC would also become
incorporated into a complex with Claspin. We also find that
Claspin interacts with the Rad17-containing RFC complex.
Recent evidence has indicated that the Rad17-containing
complex interacts with the 5 recessed ends of DNA strands
(Ellison and Stillman, 2003; Zou et al., 2003). Thus, Claspin
Figure 6 (cont). Claspin-depleted extracts (lanes 3–9) containing
control buffer (lanes 1–3), full-length His6-Claspin-FLAG (lane 4),
His6-Claspin(774-1285)-FLAG (lanes 5–7), GST-NLS-Claspin(776-
956) (lane 8), and GST-NLS-Claspin(844-1170) (lane 9) at the indi-
cated concentrations relative to endogenous Claspin were incubated
in the absence (lane 1) or presence (lanes 2–9) of aphidicolin. Phos-
phorylation of 35S-Xchk1 was detected with a phosphorimager (top)
and quantitated (bottom). Results are mean  SD for two experi-
ments. (E) The 776–905 fragment of Claspin is sufficient at a high
concentration for full phosphorylation of Xchk1. Mock-depleted
(lanes 1 and 2) and Claspin-depleted extracts (lanes 3 and 4) were
incubated with control buffer (lanes 1–3) or GST-NLS-Claspin(776-
905) (lane 4) at a molar concentration sixfold higher than that of
endogenous Claspin and examined for phosphorylation of 35S-
Xchk1. (F) Summary for identification of the CKAD from Claspin.
The CKBD is denoted with the shaded box. (G) Fragments from
C-terminal half of Claspin display little or no stable binding to
chromatin. Extracts were incubated with His6-Claspin(774-1285)-
FLAG, GST-NLS-Claspin(776-956), or GST-NLS-Claspin(776-905) in
the presence of aphidicolin (lane 2) or aphidicolin plus caffeine
(lanes 1 and 3). Polypeptides were added at 4–6 the molar con-
centration of endogenous Claspin. Nuclear (lane 1) and chromatin
fractions (lanes 2 and 3) were immunoblotted with anti-FLAG or
anti-GST antibodies to detect recombinant Claspin proteins as ap-
propriate. Samples were also immunoblotted for endogenous
Claspin, Xrad17, and Xorc2.
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would be in a position to participate in the detection of an
array of different DNA replication intermediates (Figure
7A).
Role of Claspin as a Checkpoint Sensor Protein
One important question in the cell cycle checkpoint field
involves the issue of how cells detect the presence of incom-
pletely replicated or damaged DNA. Numerous studies in
recent years have suggested that cells use a combinatorial
mechanism to detect and discriminate between arrays of
checkpoint-triggering signals (Sancar et al., 2004). Mediator
proteins such as Claspin and the BRCT-containing proteins
can provide additional modes of discrimination to check-
point-sensing mechanisms, and indeed they may be crucial
for cells to distinguish between different checkpoint-induc-
ing signals. The fact that Claspin associates strongly with
replication forks raised the possibility that this binding
would be closely related with the ability of Claspin to me-
diate the activation of Xchk1. Interestingly, however, we
find that certain fragments of Claspin retain the ability to
mediate the activation of Xchk1 without being able to asso-
ciate stably with chromatin. These fragments fall into two
classes. Fragments from the C-terminal half of Claspin retain
full efficacy for activation of Xchk1 but are significantly less
potent. For example, the 774-1285 fragment is 33-fold less
potent than full-length Claspin for half-maximal activation
of Xchk1. By contrast, a fragment containing residues 470-
1285 does not bind to chromatin stably but is nonetheless
comparable to full-length Claspin in its potency for activa-
tion of Xchk1. Significantly, this fragment retains a substan-
tial portion of the RFID, namely, BP2 (residues 470–600)
(Figure 7B). The presence of the BP2 region may allow the
470-1285 fragment to interact transiently with replication
forks and thereby enhance the ability of Claspin to mediate
the activation of Xchk1. Alternatively, it is possible that the
BP2 region increases the activity of Claspin as a mediator by
a mechanism that does not involve any interaction with
chromatin. However, our mapping studies have clearly in-
dicated that this region is important for optimal interaction
with chromatin. For example, deletion of BP2 (residues 470–
600) from full-length Claspin impaired chromatin binding in
egg extracts containing all of its endogenous Claspin, indi-
cating that this mutant cannot compete effectively with nor-
mal Claspin. Furthermore, in Claspin-depleted extracts, the
BP2 mutant can bind to chromatin, but it displays signifi-
cantly reduced ability to mediate the activation of Xchk1.
Therefore, this mutant seems to associate with chromatin in
an aberrant manner that is not compatible with normal
activation of Xchk1.
Recently, it has been shown that human Claspin and its
fission yeast relative Mrc1 possess a DBD (Sar et al., 2004;
Zhao and Russell, 2004). The DBD in human Claspin (resi-
dues 149–340) is highly homologous to residues 150–331 in
Xenopus Claspin and contains the BP1 region of the RFID
that we have identified in this study. Our results indicate
that the DBD region is not essential either for interaction
with chromatin or for activation of Xchk1. We found that
versions of Claspin that lack this region, such as the (150-
331) and 332-1285 constructs, bind very well to chromatin in
Claspin-depleted extracts and display a comparable potency
with full-length Claspin for mediating the activation of
Xchk1. Nonetheless, these mutants do seem to have a lower
affinity for replication forks in that they are unable to bind to
chromatin in undepleted extracts containing the full com-
plement of endogenous Claspin. The physiological role of
the DBD in human Claspin is not known. Fission yeast
harboring a version of Mrc1 with a mutated DBD displayed
a modest increase in sensitivity to hydroxyurea and a partial
defect in the DNA replication checkpoint. However, the
abilities of this mutant to associate with chromatin in fission
yeast cells and to mediate the activation of Cds1, the check-
point effector kinase downstream of Mrc1, have not yet been
described. We suspect that the DBD/BP1 region may have a
role in some other function of Claspin besides mediating the
activation of Xchk1.
Identification of a Minimal Chk1-activating Domain
Another finding of this work is that a very small fragment of
Claspin (the CKAD), only 130 amino acids long, is fully
sufficient at high concentrations to sustain the Xatr-depen-
dent activation of Xchk1 in aphidicolin-treated extracts. We
can detect little or no association of the CKAD with chro-
matin, which reinforces the concept that stable binding of
Claspin to chromatin is not obligatory for checkpoint acti-
vation. Nonetheless, even this small fragment presumably
interacts transiently with sites of replication to collaborate
with replication fork-associated Xatr in the phosphorylation
of Xchk1. Similarly, we can never detect binding of Xchk1 to
chromatin (our unpublished data), which implies that Xchk1
would also interact only transiently with Xatr-Xatrip and
Claspin at replication forks. Consistent with this idea,
Claspin has a low affinity for the fully activated form of
Xchk1, which presumably dissociates from Claspin immedi-
ately upon kinase activation (Jeong et al., 2003). Together,
these observations indicate that Xatr-Xatrip, Claspin, and
Xchk1 associate evanescently with one another during the
process that results in activation of Xchk1.
Figure 7. Model for the interaction of Claspin with stalled repli-
cation forks. (A) Diagram summarizes the protein–protein interac-
tions of Claspin at replication forks. See text for discussion. (B)
Summary of the different functional domains within Claspin.
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Stable Chromatin Binding of Claspin May Reflect an
Additional Function
Our observations support the possibility that the RFID has
another function in addition to initial activation of Xchk1. In
the absence of Claspin, DNA replication in egg extracts
occurs somewhat more slowly than normal (Lee et al., 2003).
Interestingly, overexpression of Claspin in human cells en-
hances the rate of cell proliferation (Lin et al., 2004). Further-
more, it is well established that the budding yeast Mrc1
protein, the apparent functional counterpart of Claspin, has
a role in DNA replication. Yeast mutants lacking Mrc1 rep-
licate their DNA more slowly, accumulate DNA damage in
S phase, and exhibit defects in sister chromatid cohesion
(Alcasabas et al., 2001; Osborn and Elledge, 2003; Xu et al.,
2004). Although the exact role that Claspin/Mrc1 plays in
S-phase regulation remains to be established, our data raise
the possibility that the stable retention of Claspin on chro-
matin may be related to this function.
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